Grand Pharmaceutical to acquire 81.03% stake in Wuhan Kernel Biotechnology - MarketLine Financial Deals

Grand Pharmaceutical to acquire 81.03% stake in Wuhan Kernel Biotechnology

Grand Pharmaceutical to acquire 81.03% stake in Wuhan Kernel Biotechnology - MarketLine Financial Deals
Grand Pharmaceutical to acquire 81.03% stake in Wuhan Kernel Biotechnology
Published Sep 22, 2011
3 pages — Published Sep 22, 2011
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Grand Pharmaceutical (China) Co., Limited, a non-wholly-owned subsidiary of China Grand Pharmaceutical and Healthcare Holdings Limited, has entered into an agreement to acquire 46,483,880 shares, representing an 81.03% stake of Wuhan Kernel Bio TechCo., Limited.

  
Source:
Document ID
MA81336_110928
Country
Country
Ticker
0512=HK
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Grand Pharmaceutical to acquire 81.03% stake in Wuhan Kernel Biotechnology" Sep 22, 2011. Alacra Store. Dec 10, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Grand-Pharmaceutical-to-acquire-81-03-stake-in-Wuhan-Kernel-Biotechnology-2052-69527>
  
APA:
MarketLine Financial Deals. (2011). Grand Pharmaceutical to acquire 81.03% stake in Wuhan Kernel Biotechnology Sep 22, 2011. New York, NY: Alacra Store. Retrieved Dec 10, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Grand-Pharmaceutical-to-acquire-81-03-stake-in-Wuhan-Kernel-Biotechnology-2052-69527>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.